Approval · Notice of Compliance 25628 · 2021
HYZAAR: Notice of Compliance 25628
Issued April 9, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25628
- Date
- April 9, 2021
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LOSARTAN POTASSIUM 50 MG per TAB
- LOSARTAN POTASSIUM 100 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB